STAT+: Astellas retries XLMTM gene therapy after deaths

Veradermics' hair loss pill late-stage trial success, FDA fast-tracks reviews for psychedelics, and more biotech news
Source
Stat News
Opens original article in a new tab
AI Bias Analysis
4 models · Takes ~15 seconds

Veradermics' hair loss pill late-stage trial success, FDA fast-tracks reviews for psychedelics, and more biotech news
Source
Stat News
Opens original article in a new tab

Years ago, Archelle Georgiou helped squash prior auths at one of America's biggest health insurers.

(MedPage Today) -- Note that some links may require registration or subscription. Periods of bereavement were linked to higher risks of heart attack and stroke, associations that were amplified during the COVID pandemic. (JAMA Network Open) Utah...

Intellia disclosed that a single dose of its gene editing treatment dramatically reduced swelling attacks in patients with hereditary angioedema

The state of Covid-19 in 2026, a hat to treat depression, and other health news from Morning Rounds